Gabapentin Determination in Human Plasma and Capsule by Coupling of Solid Phase Extraction, Derivatization Reaction, and UV-Vis Spectrophotometry

AuthorMaryam Kazemipouren
AuthorIman Fakharien
AuthorMehdi Ansarien
Issued Date2013-07-31en
AbstractGabapentin is an anticonvulsant widely used in the treatment of epilepsy. No peculiar chromophore is available on the gabapentin moiety for direct analysis by absorption spectrophotometry. A sensitive spectrophotometric method for the determination of gabapentin in bulk, pharmaceutical formulations and human plasma has been developed. In this method, gabapentin directly derivatized with vanillin and analyzed without any extraction in bulk and pharmaceutical dosage form and in plasma samples, it was extracted with a reversed-phase solid-phase extraction (SPE) cartridge followed by derivatization with vanillin. Analysis was performed by a spectrophotometer system. The quantitation limit of gabapentin in human plasma was 0.8 mg/L. The method was linear over the concentration range of 10.0–90.0 mg/L and 0.8–10.0 mg/L for pharmaceutical dosage form and plasma, respectively. The method was precise (relative standard deviation, RSDen
DOIhttps://doi.org/10.22037/ijpr.2013.1347en
KeywordGabapentinen
KeywordSpectrophotometryen
KeywordDerivatizationen
KeywordSPEen
KeywordPlasmaen
KeywordVanillinen
PublisherBrieflandsen
TitleGabapentin Determination in Human Plasma and Capsule by Coupling of Solid Phase Extraction, Derivatization Reaction, and UV-Vis Spectrophotometryen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-12-247.pdf
Size:
698.94 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF